Real world evidence (RWE) is playing an increasingly prominent role in healthcare decisions by adding an important new dimension to patient care. It has been often used to inform decisions on care, drug pricing, and coverage in Europe and North America.
Ongoing efforts to incorporate RWE into drug development and regulatory processes are also seen in these regions. In recent years there is significant and growing interest in the use of RWE in the Asia Pacific region. In this webinar, the leading RWE experts in the region will share their perspectives on the benefits, limitations, and challenges of RWE. Case studies of the use of RWE in decision making will be presented.
- Deepen the understanding of RWE
- Identify barriers and potential solutions to adoption of RWE generation; and
- Learn how to leverage RWE in healthcare decision processes.